SANGAMO BIOSCIENCES, INC.

Patent Owner

Compare Create Portfolio
4Status Updates

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
 
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 11852
 
 
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 3580
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 34211
 
 
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 2973
 
 
 
C07K PEPTIDES 2883
 
 
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 2076
 
 
 
A01H NEW PLANTS OR PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES 7113
 
 
 
A01K ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS734
 
 
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 7168
 
 
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 667

Top Patents (by citation)

Upgrade to the Premium Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2015/0037,304 METHODS AND COMPOSITIONS FOR MODIFICATION OF HLAMar 12, 14Feb 05, 15[C12N, A61K]
2015/0031,090 METHODS AND COMPOSITIONS FOR TARGETED GENOMIC DELETIONSep 30, 14Jan 29, 15[C12N]
2014/0335,063 DELIVERY METHODS AND COMPOSITIONS FOR NUCLEASE-MEDIATED GENOME ENGINEERINGMay 06, 14Nov 13, 14[C12N, A01K, A61K]
2014/0325,691 REGULATION OF ENDOGENOUS GENE EXPRESSION IN CELLS USING ZINC FINGER PROTEINSJun 05, 14Oct 30, 14[A01K, C12Q, G01N]
2014/0301,990 TARGETED DISRUPTION OF T CELL RECEPTOR GENES USING ENGINEERED ZINC FINGER PROTEIN NUCLEASESMar 20, 14Oct 09, 14[C12N, A61K]
2014/0304,853 METHODS AND COMPOSITIONS FOR INTEGRATION OF AN EXOGENOUS SEQUENCE WITHIN THE GENOME OF PLANTSApr 02, 14Oct 09, 14[C12N]
2014/0273,097 METHODS AND COMPOSITIONS FOR INACTIVATING ALPHA 1,6 FUCOSYLTRANSFERASE (FUT8) GENE EXPRESSIONMay 28, 14Sep 18, 14[C12N, C12P, C07K]
2014/0242,702 METHODS AND COMPOSITIONS FOR ENHANCING NUCLEASE-MEDIATED GENE DISRUPTIONFeb 24, 14Aug 28, 14[C12N]
2014/0234,970 MODULATION OF STEM CELLS USING ZINC FINGER PROTEINSMay 05, 14Aug 21, 14[C12N]
2014/0212,928 METHODS AND COMPOSITIONS FOR TARGETED SINGLE-STRANDED CLEAVAGE AND TARGETED INTEGRATIONMar 06, 14Jul 31, 14[C12N]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
8,956,828 Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleasesNov 10, 10Feb 17, 15[C12N, C07H, C12P, A61K]
8,945,868 Methods and compositions for modification of a HLA locusJul 21, 11Feb 03, 15[C12N, C12P, C07K]
8,936,936 Methods and compositions for targeted integrationOct 23, 08Jan 20, 15[C12N]
8,921,112 Optimized non-canonical zinc finger proteinsOct 01, 08Dec 30, 14[C12N, A01H]
8,912,138 DNA-binding proteins and uses thereofOct 28, 13Dec 16, 14[C12N, A61K]
8,895,264 locusOct 25, 12Nov 25, 14[C12N, C07H, C12Q, C07K]
8,889,390 Engineered zinc finger proteins targeting 5-enolpyruvyl shikimate-3-phosphate synthase genesFeb 13, 13Nov 18, 14[C12N]
8,871,905 Modification of CXCR4 using engineered zinc finger proteinsMar 18, 10Oct 28, 14[C12N, A61K, C07K]
8,841,260 Methods and compositions for treating Huntington's DiseaseFeb 28, 13Sep 23, 14[A61K, C07K]
8,822,221 Targeted integration into the PPP1R12C locusDec 30, 11Sep 02, 14[C12N]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Filing Date Issue/Pub Date Intl Class
2012/0214,241 ZINC FINGER NUCLEASE MODIFICATION OF LEUCINE RICH REPEAT KINASE 2 (LRRK2) MUTANT FIBROBLASTS AND IPSCSDec 15, 11Aug 23, 12[C12N]
2012/0204,282 METHODS AND COMPOSITIONS FOR TREATING OCCULAR DISORDERSFeb 06, 12Aug 09, 12[C12N, C07H, A01K, A61P, A61K, C07K]
2012/0196,370 METHODS AND COMPOSITIONS FOR TARGETED GENOMIC DELETIONDec 02, 11Aug 02, 12[C12N]
2012/0088,677 METHODS AND COMPOSITIONS FOR ANALYSIS OF REGULATORY SEQUENCESDec 19, 11Apr 12, 12[C40B]
2011/0306,559 METHODS AND COMPOSITIONS FOR TREATING NEUROPATHIC PAINDec 23, 09Dec 15, 11[C12N, C07H, A61P, A61K, C07K]
2011/0281,937 Methods and compositions for treating neuropathic and neurodegenerative conditionsJan 03, 11Nov 17, 11[A61P, A61K]
2011/0244,474 Rapid screening of biologically active nucleases and isolation of nuclease-modified cellsApr 28, 11Oct 06, 11[C12N, C07H, C12Q]
2011/0247,089 Organisms homozygous for targeted modificationApr 20, 11Oct 06, 11[C12N, A01K, A01H]
2011/0014,616 Rapid screening of biologically active nucleases and isolation of nuclease-modified cellsJun 29, 10Jan 20, 11[C12N, C07H, C12Q]
2010/0311,124 Methods and compositions for inactivating glutamine synthetase gene expressionJul 09, 10Dec 09, 10[C12N, C12P]
2010/0279,406 Alteration of tumor growth using zinc finger proteinsSep 20, 06Nov 04, 10[C12N]
2010/0261,271 Regulation of endogenous gene expression in cells using zinc finger proteinsSep 14, 06Oct 14, 10[C12N]
2010/0256,221 Methods and compositions for treating neuropathic and neurodegenerative conditionsOct 08, 09Oct 07, 10[A61P, A61K]
2010/0111,907 Methods and compositions for gene inactivationOct 15, 09May 06, 10[C12N, A61P, A61K]
2009/0305,402 Methods and compositions for using zinc finger endonucleases to enhance homologous recombinationJun 11, 09Dec 10, 09[C12N]
2009/0305,977 Method for treating peripheral arterial disease with zinc finger proteinsFeb 09, 07Dec 10, 09[A61K]
2009/0263,900 Linear donor constructs for targeted integrationApr 13, 09Oct 22, 09[C12N, C07H]
7,605,140 Regulation of angiogenesis with zinc finger proteinsApr 26, 05Oct 20, 09[A61K]
2009/0215,878 TREATMENT OF CHRONIC PAIN WITH ZINC FINGER PROTEINSFeb 06, 09Aug 27, 09[C12N, A61K, C07K]
2009/0203,140 Genomic editing in zebrafish using zinc finger nucleasesSep 25, 08Aug 13, 09[C12N]

View all patents..

Top Inventors for This Owner

Upgrade to the Premium Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.